Retinal microvascular alterations assessed by OCTA in metabolic liver disease: insights into systemic microvascular dysfunction—a systematic review and semi-quantitative synthesis
- 1Department of Ophthalmology, Ruijin-Hainan Hospital, Shanghai Jiao Tong University School of Medicine (Hainan Boao Research Hospital), Qionghai, Hainan, China
- 2Department of Gastroenterology and Hepatology, Ruijin-Hainan Hospital, Shanghai Jiao Tong University School of Medicine (Hainan Boao Research Hospital), Qionghai, Hainan, China
Abstract
BackgroundMetabolic liver disease, historically characterized as nonalcoholic fatty liver disease (NAFLD) and recently redefined as metabolic dysfunction-associated steatotic liver disease (MASLD), has emerged as a global public health crisis. It is increasingly recognized not merely as a liver-specific pathology, but as a complex multisystemic disorder strongly associated with widespread systemic microvascular dysfunction. The retina, sharing similar anatomical and physiological features with the systemic microcirculation, provides a unique, *in vivo* window for non-invasive vascular assessment.MethodsA systematic review with semi-quantitative synthesis was conducted in strict adherence to the PRISMA guidelines. We comprehensively searched the PubMed, Embase, and Cochrane Library databases for relevant studies published from inception to March 2026. Studies employing optical coherence tomography angiography (OCTA) to evaluate the macular microvasculature in patients with metabolic liver disease were included. Study quality was rigorously appraised using the Newcastle–Ottawa Scale (NOS).ResultsA total of 7 cross-sectional and retrospective studies encompassing approximately 520 participants met the stringent inclusion criteria. Across the included cohorts, a consistent and statistically significant reduction in retinal vessel density (VD) was observed. Notably, this vascular rarefaction was predominantly localized within the deep capillary plexus (DCP). Furthermore, an abnormal enlargement of the foveal avascular zone (FAZ) was consistently reported in patients with metabolic liver disease compared to matched healthy controls, indicating subclinical macular ischemia.ConclusionMetabolic liver disease is significantly associated with early retinal microvascular alterations detectable by OCTA, preceding visually significant ocular symptoms. These subclinical findings highlight a profound pathological link between hepatic steatosis and systemic microvascular dysfunction. OCTA metrics, particularly DCP vessel density and FAZ area, may serve as novel, non-invasive biomarkers for identifying patients at high risk for systemic vascular complications.
Related
- Association of adverse pregnancy outcomes with coronary microvascular dysfunction: a systematic review and meta-analysis
- Retinal and Choroidal Microvascular Changes Across the Migraine Attack Cycle: A Systematic Review and Exploratory Quantitative Synthesis
- Low-intensity pulsed ultrasound for erectile dysfunction: a systematic review and limited quantitative synthesis
- Integrated multi-omics identifies distinct macrophage alterations during progression of metabolic dysfunction-associated steatohepatitis
- Coronary microvascular dysfunction in patients undergoing transcatheter aortic valve implantation: A systematic review and meta-analysis
BibTeX
@article{wang2026retinal,
title = {{Retinal microvascular alterations assessed by OCTA in metabolic liver disease: insights into systemic microvascular dysfunction—a systematic review and semi-quantitative synthesis}},
author = {Xu Wang and Zi-qiang Meng},
journal = {Frontiers in Medicine},
year = {2026},
month = oct,
doi = {10.3389/fmed.2026.1897327},
url = {https://doi.org/10.3389/fmed.2026.1897327},
note = {CC BY},
}
RIS
TY - JOUR
TI - Retinal microvascular alterations assessed by OCTA in metabolic liver disease: insights into systemic microvascular dysfunction—a systematic review and semi-quantitative synthesis
AU - Xu Wang
AU - Zi-qiang Meng
PY - 2026
DA - 2026/10/27
JO - Frontiers in Medicine
DO - 10.3389/fmed.2026.1897327
UR - https://doi.org/10.3389/fmed.2026.1897327
AB - BackgroundMetabolic liver disease, historically characterized as nonalcoholic fatty liver disease (NAFLD) and recently redefined as metabolic dysfunction-associated steatotic liver disease (MASLD), has emerged as a global public health crisis. It is increasingly recognized not merely as a liver-specific pathology, but as a complex multisystemic disorder strongly associated with widespread systemic microvascular dysfunction. The retina, sharing similar anatomical and physiological features with the systemic microcirculation, provides a unique, *in vivo* window for non-invasive vascular assessment.MethodsA systematic review with semi-quantitative synthesis was conducted in strict adherence to the PRISMA guidelines. We comprehensively searched the PubMed, Embase, and Cochrane Library databases for relevant studies published from inception to March 2026. Studies employing optical coherence tomography angiography (OCTA) to evaluate the macular microvasculature in patients with metabolic liver disease were included. Study quality was rigorously appraised using the Newcastle–Ottawa Scale (NOS).ResultsA total of 7 cross-sectional and retrospective studies encompassing approximately 520 participants met the stringent inclusion criteria. Across the included cohorts, a consistent and statistically significant reduction in retinal vessel density (VD) was observed. Notably, this vascular rarefaction was predominantly localized within the deep capillary plexus (DCP). Furthermore, an abnormal enlargement of the foveal avascular zone (FAZ) was consistently reported in patients with metabolic liver disease compared to matched healthy controls, indicating subclinical macular ischemia.ConclusionMetabolic liver disease is significantly associated with early retinal microvascular alterations detectable by OCTA, preceding visually significant ocular symptoms. These subclinical findings highlight a profound pathological link between hepatic steatosis and systemic microvascular dysfunction. OCTA metrics, particularly DCP vessel density and FAZ area, may serve as novel, non-invasive biomarkers for identifying patients at high risk for systemic vascular complications.
SN - 2296-858X
ER -